Designed for accuracy and long life
Senseonics is a medical technology company focused on the design, development and commercialization of glucose monitoring systems to improve the lives of people with diabetes by enhancing their ability to manage this disease with relative ease and accuracy.
- Senseonics Executes Agreement with Diasend
- Senseonics Holdings, Inc. and ASN Technologies, Inc. Announce Closing of Merger
- Senseonics Reports CGM Europe Pivotal Study Results. Primary Effectiveness and Safety Endpoints Met; CE Mark Pending.
- Scientific posters related to the usability of the Senseonics CGM System during a multi-site study was presented at the Diabetes Technology Meeting October 2015.